LOGIN  |  REGISTER

Recent Insider Transactions - Fate Therapeutics (NASDAQ: FATE)

Follow NASDAQ:FATE Visit website
Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ FATE Fate Therapeutics
RedCo II Master Fund, L.P. / director, 10 percent owner:
07/02/2025
Sell
$5.84
266,280
$1.555M
0
NASDAQ FATE Fate Therapeutics
Lee Michael Stewart / director
05/29/2025
Buy
$1.32
55,000
$73K
55,000
NASDAQ FATE Fate Therapeutics
Redmile Group, LLC / director, 10 percent owner:
05/29/2025
Buy
$1.32
55,000
$73K
55,000
NASDAQ FATE Fate Therapeutics
Xu Yuan / director
05/29/2025
Buy
$1.32
55,000
$73K
55,000
NASDAQ FATE Fate Therapeutics
Mozaffarian Neelufar / director
05/29/2025
Buy
$1.32
55,000
$73K
55,000
NASDAQ FATE Fate Therapeutics
RASTETTER WILLIAM H / director
05/29/2025
Buy
$1.32
55,000
$73K
55,000
NASDAQ FATE Fate Therapeutics
MENDLEIN JOHN / director
05/29/2025
Buy
$1.32
55,000
$73K
55,000
NASDAQ FATE Fate Therapeutics
Jooss Karin / director
05/29/2025
Buy
$1.32
55,000
$73K
55,000
NASDAQ FATE Fate Therapeutics
EPSTEIN ROBERT S / director
05/29/2025
Buy
$1.32
55,000
$73K
55,000
NASDAQ FATE Fate Therapeutics
ABERNETHY MATT / director
05/29/2025
Buy
$1.32
110,000
$145K
110,000
NASDAQ FATE Fate Therapeutics
Agarwal Shefali / director
05/29/2025
Buy
$1.32
55,000
$73K
55,000

  Research Tools
  News & Announcements
  Popular Topics
  Miscellaneous